APA (7th ed.) Citation

P, B., G, E., C, A., F, d., M, A., I, C., . . . F, V. (2022). Correction to: Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study). The journal of headache and pain, 23(1), 51. https://doi.org/10.1186/s10194-022-01422-y

Chicago Style (17th ed.) Citation

P, Barbanti, et al. "Correction to: Fremanezumab in the Prevention of High-frequency Episodic and Chronic Migraine: A 12-week, Multicenter, Real-life, Cohort Study (the FRIEND Study)." The Journal of Headache and Pain 23, no. 1 (2022): 51. https://doi.org/10.1186/s10194-022-01422-y.

MLA (9th ed.) Citation

P, Barbanti, et al. "Correction to: Fremanezumab in the Prevention of High-frequency Episodic and Chronic Migraine: A 12-week, Multicenter, Real-life, Cohort Study (the FRIEND Study)." The Journal of Headache and Pain, vol. 23, no. 1, 2022, p. 51, https://doi.org/10.1186/s10194-022-01422-y.